Recombinant human granulocyte/macrophage colony-stimulating factor (Fuyang Cancer Hospital)

重组人粒细胞/巨噬细胞集落刺激因子（阜阳市肿瘤医院）

Report date: 2024/05/16 13:24:32

Base Information

Drug NameRecombinant human granulocyte/macrophage colony-stimulating factor (Fuyang Cancer Hospital)

Drug Alias NamerhGM-CSF (Fuyang Cancer Hospital)Molgramostim biosimilar (Fuyang Cancer Hospital)Molgramostim follow-on biologic (Fuyang Cancer Hospital)

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants

TargetsGranulocyte-macrophage colony-stimulating factor receptor

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesFuyang Cancer Hospital (Yingdong District People'S Hospital Of Fuyang City)

China Registration ClassN/A

Develop Information

Active CompaniesFuyang Cancer Hospital (Yingdong District People'S Hospital Of Fuyang City)

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A